- In April 2024, Domer Technology (U.S.) launched two new cold laser therapy devices: the Domer Laser Class 3B and the high-intensity Class 4 Laser. These devices are designed to treat conditions such as joint injuries, tendonitis, fractures, and inflammation. The Class 3B laser offers a 500mW output, while the Class 4 laser provides an output over 500mW, reducing treatment time to 5-10 minutes. Both lasers work by promoting blood flow, cellular repair, and pain reduction, offering a non-invasive alternative to traditional treatments, improving recovery speed, and providing effective pain management
- In May 2024, APEX Brain Centers (U.S.) unveiled advancements in Low-Level Laser Therapy (LLLT), a key modality in their therapeutic approach. This technology aims to enhance brain health by stimulating cellular energy production, reducing inflammation, and promoting healing in neurological conditions. LLLT is integrated into their treatment plans for cognitive impairments, brain injuries, and various behavioural disorders. It helps to accelerate tissue repair, manage pain, and reduce inflammation non-invasively. The benefits include improved neuroplasticity, brain function, and potential neuroprotection for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's disease
Frequently Asked Questions
The major factors driving the growth of the cold laser therapy market are rising preference for non-invasive treatments and technological advancements in laser devices.
The primary challenges include limited reimbursement and insurance coverage and lack of awareness and education.
The instruments segment is expected to dominate the global cold laser therapy market, holding a major market share in 2025.
